Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v2-FR
Language French French
Date Updated 2019-06-04 2018-12-04
Drug Identification Number 02439662 02439662
Brand name ACT BUPROPION XL ACT BUPROPION XL
Common or Proper name BUPROPION XL BUPROPION XL
Company Name ACTAVIS PHARMA COMPANY ACTAVIS PHARMA COMPANY
Ingredients BUPROPION HYDROCHLORIDE BUPROPION HYDROCHLORIDE
Strength(s) 300MG 300MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 500
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-12-01 2018-12-01
Estimated end date 2019-07-30 2019-03-30
Actual end date
Shortage status Actual shortage Actual shortage
Company comments Inventory being allocated for regular demand. Cannot take on additional demand for this molecule. Inventory being allocated for regular demand. Cannot take on additional demand for this molecule.
Health Canada comments